quartiles were computed in Microsoft Excel and the upper range for outliers was set at quartile 3 + (1.5 the IQR), and the lower range was set at quartile 1 (1.5 the IQR)
Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
Participation in another clinical trial within 90 days before screening
If you take a daily B12 supplement or multivitamin and your levels are mildly elevated (900 to 1,200 pg/mL), the most likely explanation is the supplement
Despite its importance, B12 deficiency is remarkably common particularly among vegetarians, older adults, individuals with digestive conditions, and anyone whose body has difficulty absorbing this vitamin from food or oral supplements
Available evidence suggests AHK-Cu is well tolerated with topical application